Skip to main content
. 2021 Nov 26;10(6):1077–1084. doi: 10.1093/toxres/tfab107

Table 1.

Shikonin induces tumor cell apoptosis

Cancer types Cell types Molecular mechanism References
Glioma U251 and U87MG cells Downregulation of CD147 [87]
Non-small cell lung cancer A549 cells Inhibited the STAT3 and AKT pathways, downregulated the expression of Bcl-2 [88]
Breast cancer 4 T1 and MDA-MB-231 cells Regulated p38 signaling pathways [15]
Hpatocellular cancer huh7 and BEL7402 cells Induced reactive oxygen species (ROS), downregulation of AKT and RIP1/NF-κB activity [24]
Gastric cancer AGS、AZ521 and SCM-1 cells Upregulated p38 activities,inhibited ERK1/2 and AKT activities [17]
Glioma GBM、U87MG、DK-MG cells Inhibited the epidermal growth factor receptor signaling pathway [52]
Melanoma A357 cells Activated ROS-mediated ER stress and p38 pathways [74, 89]
Non-small cell lung cancer A549 and NCI-H1437 cells Activated FOXO3a/EGR1/SIRT1 signaling [90]
Gastric carcinoma AGS cells Regulated p53 and Nrf2 signaling pathways [91]
Thyroid carcinoma TT cells Through the mitochondrial signaling pathway [16]
Gastric cancer NCI-N87 cells Inhibition of PI3K/AKT signal pathway [40]
Leukemia K562 cells Increased the PTEN level and inactivated the PI3K/AKT signaling pathway [44]